Epcoritamab

Epcoritamab

Pida mas información

935106861

info@markelab.com

Precio

387.5€ (100 µg)

proveedor

Abbexa

reference

abx831545

Tested Applications

ELISA, WB

reactivity

Human

status

This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications (RUO

clonality

Monoclonal

Descripción

Epcoritamab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CD3E/MS4A1/CD20, Epcoritamab (DuoBody®-CD3xCD20) is a proprietary bispecific antibody created using Genmab’s DuoBody technology. It targets CD20 on the B-cells, a clinically well-validated target that is expressed in a wide variety of B-cell malignancies. Epcoritamab is currently under investigation in a Phase I/II study for multiple hematological B cell malignancies.

Características del producto

category

Biosimilars


host

Human


clonality

Monoclonal


reactivity

Human


immunogen target

CD3E/MS4A1/CD20


host

Human


isotype

IgG4 Kappa-Lambda


conjugation

Unconjugated


form

Liquid


tested applications

ELISA, WB


size 1

100 µg


size 2

1 mg


expression

Recombinant


purity

> 95%


purification

Purified from cell culture supernatants by Protein A/G chromatography.


buffer

0.01 M PBS. pH 7.4.


storage

Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.


dry ice

No


availability

Shipped within 7-12 working days.


alias

Biosimilars


Quizá le pueda interesar

Goat MAP28 ELISA Kit

Goat MAP28 ELISA Kit

proveedor

FineTest

reference

EG0012

reactivity

goat

status

RUO

Precio a consultar

Ver más

HRP conjugated Streptavidin

HRP conjugated Streptavidin

proveedor

FineTest

reference

FNSA-0001

Tested Applications

ELISA, WB

status

RUO

Precio a consultar

Ver más

HRP conjugated Goat Anti-Mouse FC

HRP conjugated Goat Anti-Mouse FC

proveedor

FineTest

reference

FNSA-0002

Tested Applications

ELISA, WB

reactivity

mouse

status

RUO

Precio a consultar

Ver más